Financial News
Articles published by NanoVibronix, Inc.
NanoVibronix Issues Letter to Stockholders
April 09, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Signs Agreement for Research and Development of Next Generation PainShield and UroShield
March 28, 2024
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Featured in Your Bladder Health Magazine
December 06, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Announces Agreement for Clinical Study of UroShield at the University of Michigan
November 28, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Regains Nasdaq Compliance
November 21, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Issues Letter to Shareholders
November 14, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Gains Approval for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
September 27, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Announces Presentation of Positive Independent Testing Results of UroShield at ICS Annual Meeting
September 06, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Announces $5 Million Private Placement Priced At-The-Market Under Nasdaq Rules
August 30, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Responds to CMS’ Determination for PainShield
August 29, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Applies for Inclusion of UroShield Products in NHS Prescription Services’ Drug Tariff
August 28, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus
August 23, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Issues Letter to Shareholders
May 18, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Issues Letter to Shareholders
April 18, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Regains Nasdaq Compliance
March 03, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix to Launch Rental Program for PainShield and UroShield
February 22, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Announces Reverse Stock Split
February 08, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Provides Update on Expanding Access to PainShield
January 18, 2023
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Announces Partnership with Peak Medical, Ltd.
December 13, 2022
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Announces Closing of $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
December 01, 2022
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Announces $2.4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
November 29, 2022
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
NanoVibronix Receives FDA 510(k) Premarket Clearance for PainShield Plus
November 28, 2022
From NanoVibronix, Inc.
Via Business Wire
Tickers
NAOV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.